Forecast & Rating2 analysts currently cover Biovie, of which 2 give a positive rating. The average price target is $5.26, about 226.4% upside from the current price of $1.61. Coverage is limited, so the data is for reference only. Data as of Jul 23, 2026; this does not constitute investment advice.
Jul 22, 2026Price forecast
$5.25226.40%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met19.8%
Stock price$1.61
Avg. target$12.0
High target$12
Low target$12
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.